| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 Feb 2025 | 27 Feb 2025 |
| Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 27, 2025. | ||
| Board Meeting | 9 Nov 2024 | 5 Nov 2024 |
| To consider and approve the financial results for the period ended September 30, 2024, interim dividend and other business matters REMUS PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 09-Nov-2024 for Dividend (As Per NSE Announcement Dated on: 09/11/2024) | ||
| Board Meeting | 14 Aug 2024 | 14 Aug 2024 |
| Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 14, 2024. | ||
| Board Meeting | 10 Jun 2024 | 10 Jun 2024 |
| Remus Pharmaceuticals Limited has informed the Exchange regarding allotment of 4419000 equity shares pursuant to Bonus at its meeting held on Jun 10, 2024 | ||
| Board Meeting | 16 May 2024 | 9 May 2024 |
| To consider and approve the financial results for the period ended March 31, 2024 and other business matters Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2024. (As Per BSE Announcement Dated on: 16/05/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
